Modification of virus infectivity by cytoplasmic tail of HIV-1 TM protein

Virus Research

Volumn 74, Issue 1-2, 2001, Pages 75-87

  Iwatani, Yasumasa ^a,b   Ueno, Takaharu ^a   Nishimura, Akiko ^a   Zhang, Xiaoyan ^a   Hattori, Toshio ^a   Ishimoto, Akinori ^a   Ito, Masahiko ^b   Sakai, Hiroyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Cytoplasmic tail; Env incorporation; HIV 1; TM protein

Indexed keywords

GLYCOPROTEIN GP 41; M PROTEIN; TRANSMEMBRANE GP 41; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN MODIFICATION; VIRION; VIRUS INFECTIVITY; VIRUS MUTANT;

CELL LINE; CYTOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELA CELLS; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MUTATION; PLASMIDS; PROTEIN PRECURSORS; PROTEIN STRUCTURE, TERTIARY; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035110907     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(00)00249-5     Document Type: Article

References (34)

1. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies
2. Methods for HIV/SIV gene analysis
3. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site
4. The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity
5. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes
6. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein
7. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: Requirement of precursor cleavage for glycoprotein incorporation
8. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity
9. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: Analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses
10. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160
11. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix
12. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions
13. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins
14. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells
15. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants
16. SIV adaptation to human cells
17. Significance of premature stop codons in env of simian immunodeficiency virus
18. Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity
19. + T lymphocytes
20. The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells
21. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
22. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains
23. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1
24. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions
25. Characterization of human immunodeficiency virus type 1 matrix revertants: Effects on virus assembly, Gag processing, and Env incorporation into virions
26. Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells
27. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI
28. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus
29. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles
30. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain
31. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product
32. Analysis of the murine leukemia virus R peptide: Delineation of the molecular determinants which are important for its fusion inhibition activity
33. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions
34. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions